Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins

被引:458
作者
Gonzalez-Periz, Ana [1 ]
Horrillo, Raquel [1 ]
Ferre, Natalia [1 ]
Gronert, Karsten [3 ]
Dong, Baiyan [3 ]
Moran-Salvador, Eva [1 ]
Titos, Esther [1 ]
Martinez-Clemente, Marcos [1 ]
Lopez-Parra, Marta [1 ]
Arroyo, Vicente [2 ]
Claria, Joan [1 ]
机构
[1] Univ Barcelona, Dept Biochem & Mol Genet, Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Spain
[2] Univ Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Spain
[3] Univ Calif Berkeley, Sch Optometry, Ctr Eye Dis & Dev, Berkeley, CA 94720 USA
关键词
adiponectin; fatty liver disease; adipose tissue; lipid mediators; FATTY LIVER; DOCOSAHEXAENOIC ACID; ADIPOSE-TISSUE; LIPID MEDIATORS; PPAR-GAMMA; TNF-ALPHA; INFLAMMATION; RESOLUTION; MICE; E1;
D O I
10.1096/fj.08-125674
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Omega-3-polyunsaturated fatty acids (omega 3-PUFAs) have well-documented protective effects that are attributed not only to eicosanoid inhibition but also to the formation of novel biologically active lipid mediators (i.e., resolvins and protectins). In this study, we examined their effects on ob/ob mice, an obesity model of insulin resistance and fatty liver disease. Dietary intake of omega-3-PUFAs had insulin-sensitizing actions in adipose tissue and liver and improved insulin tolerance in obese mice. Genes involved in insulin sensitivity (PPAR gamma), glucose transport (GLUT-2/GLUT-4), and insulin receptor signaling (IRS-1/IRS-2) were up-regulated by omega-3-PUFAs. Moreover, omega-3-PUFAs increased adiponectin, an anti-inflammatory and insulin-sensitizing adipokine, and induced AMPK phosphorylation, a fuel-sensing enzyme and a gatekeeper of the energy balance. Concomitantly, hepatic steatosis was alleviated by omega-3-PUFAs. A lipidomic analysis with liquid chromatography/mass spectrometry/mass spectrometry revealed that omega-3-PUFAs inhibited the formation of omega-6-PUFA-derived eicosanoids, while triggering the formation of omega-3-PUFA-derived resolvins and protectins. Moreover, representative members of these lipid mediators, namely resolvin E1 and protectin D1, mimicked the insulin-sensitizing and antisteatotic effects of omega-3-PUFAs and induced adiponectin expression to a similar extent that of rosiglitazone, a member of the thiazolidinedione family of antidiabetic drugs. Taken together, these findings uncover beneficial actions of omega-3-PUFAs and their bioactive lipid autacoids in preventing obesity-induced insulin resistance and hepatic steatosis.-Gonzalez-Periz, A., Horrillo, R., Ferre, N., Gronert, K., Dong, B., Moran-Salvador, E., Titos, E., Martinez-Clemente, M., Lopez-Parra, M., Arroyo, V., Claria, J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23, 1946-1957 (2009)
引用
收藏
页码:1946 / 1957
页数:12
相关论文
共 55 条
[1]
Omega-3 fatty acids improve hepatic steatosis in a murine model:: Potential implications for the marginal steatotic liver donor [J].
Alwayn, IPJ ;
Andersson, C ;
Zauscher, B ;
Gura, K ;
Nosé, V ;
Puder, M .
TRANSPLANTATION, 2005, 79 (05) :606-608
[2]
Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[3]
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis [J].
Arita, M ;
Yoshida, M ;
Hong, S ;
Tjonahen, E ;
Glickman, JN ;
Petasis, NA ;
Blumberg, RS ;
Serhan, CN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (21) :7671-7676
[4]
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 [J].
Arita, M ;
Bianchini, F ;
Aliberti, J ;
Sher, A ;
Chiang, N ;
Hong, S ;
Yang, R ;
Petasis, NA ;
Serhan, CN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :713-722
[5]
Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation [J].
Arita, Makoto ;
Ohira, Taisuke ;
Sun, Yee-Ping ;
Elangovan, Siva ;
Chiang, Nan ;
Serhan, Charles N. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (06) :3912-3917
[6]
Chemerin is a novel adipokine associated with obesity and metabolic syndrome [J].
Bozaoglu, Kiymet ;
Bolton, Kristy ;
McMillan, Janine ;
Zimmet, Paul ;
Jowett, Jeremy ;
Collier, Greg ;
Walder, Ken ;
Segal, David .
ENDOCRINOLOGY, 2007, 148 (10) :4687-4694
[7]
n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases [J].
Calder, Philip C. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (06) :1505S-1519S
[8]
Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution [J].
Campbell, Eric L. ;
Louis, Nancy A. ;
Tomassetti, Sarah E. ;
Canny, Geraldine O. ;
Arita, Makoto ;
Serhan, Charles N. ;
Colgan, Sean P. .
FASEB JOURNAL, 2007, 21 (12) :3162-3170
[9]
Nonalcoholic fatty liver disease [J].
Clark, JM ;
Brancati, FL ;
Diehl, AM .
GASTROENTEROLOGY, 2002, 122 (06) :1649-1657
[10]
Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis [J].
Connor, Kip M. ;
SanGiovanni, John Paul ;
Lofqvist, Chatarina ;
Aderman, Christopher M. ;
Chen, Jing ;
Higuchi, Akiko ;
Hong, Song ;
Pravda, Elke A. ;
Majchrzak, Sharon ;
Carper, Deborah ;
Hellstrom, Ann ;
Kang, Jing X. ;
Chew, Emily Y. ;
Salem, Norman, Jr. ;
Serhan, Charles N. ;
Smith, Lois E. H. .
NATURE MEDICINE, 2007, 13 (07) :868-873